Loading...
Market
Will FluMist nasal spray vaccine be available in all 50 states by end of 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from AstraZeneca, FDA, or state health departments
Story
FDA Approves First At-Home FluMist for Self-Administration
Sep 20, 2024, 05:32 PM
The U.S. Food and Drug Administration (FDA) has approved AstraZeneca's FluMist nasal spray vaccine for self- or caregiver-administration. This makes FluMist the first influenza vaccine that can be administered without the need for a healthcare provider. The approval, announced on Friday, covers individuals aged 2 through 49 years and aims to expand consumer access to medicines, reduce costs, and lower barriers to care. The vaccine will be available through third-party pharmacies, where individuals will complete a screening and eligibility assessment when ordering the vaccine. The approval also marks the first at-home flu vaccine in the U.S.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pharmacies • 25%
Online retailers • 25%
Healthcare providers • 25%
Other • 25%